Risk factors for chronic GVH disease
. | Odds ratio (95% CI) . | P . |
---|---|---|
All evaluable patients (n = 280) | ||
Female to male transplantation | 3.740 (1.969-7.529) | < .0001 |
Diagnosis of ALL | 0.384 (0.184-0.773) | .0072 |
Patients with CD34, T, and NK cell numbers available (n = 222) | ||
Female to male transplantation | 5.267 (2.489-12.316) | < .0001 |
Diagnosis of ALL | 0.414 (0.178-0.923) | .031 |
T-cell number5-150 | 1.003 (1.001-1.004) | < .0001 |
CD34 number5-151 | 0.941 (0.867-0.994) | .025 |
Acute GVH disease above stage 2 | 2.707 (1.443-5.180) | .0018 |
. | Odds ratio (95% CI) . | P . |
---|---|---|
All evaluable patients (n = 280) | ||
Female to male transplantation | 3.740 (1.969-7.529) | < .0001 |
Diagnosis of ALL | 0.384 (0.184-0.773) | .0072 |
Patients with CD34, T, and NK cell numbers available (n = 222) | ||
Female to male transplantation | 5.267 (2.489-12.316) | < .0001 |
Diagnosis of ALL | 0.414 (0.178-0.923) | .031 |
T-cell number5-150 | 1.003 (1.001-1.004) | < .0001 |
CD34 number5-151 | 0.941 (0.867-0.994) | .025 |
Acute GVH disease above stage 2 | 2.707 (1.443-5.180) | .0018 |